Effects of a health education program on cytokines and cortisol levels in fibromyalgia patients: a randomized controlled trial

Table 4 Intergroup analysis at the eleventh week

	VariationEG (EGV)	Variation CG (CGV)	MD (EGV minus CGV)	95%CI	p value
IL2	−0.56	− 0.58	0.47 ± 0.77	− 1.09 to 2.03	0.54
IL4	0.76	−0.64	1.48 ± 0.53*	0.40 to 2.56*	< 0.01*
IL6	1.28	− 1.10	4.98 ± 2.69	−0.46 to 10.42	0.07
IL10	0.17	−0.23	0.39 ± 0.18*	0.01 to 0.76*	0.04*
TNF	0.04	−0.31	0.12 ± 0.32	− 0.53 to 0.78	0.70
IL17	0.42	1.04	−2.66 ± 4.09	−10.95 to 5.62	0.51
AC/IC ratio	0.05	−0.04	0.10 ± 0.04*	0.01 to 0.19*	0.03*
Cortisol	0,98	−0.32	1.35 ± 0.61*	1.11 to 2.60*	0.03*
FIQ	−30.36	2.62	−31.42 ± 5.70*	− 42.96 to − 19.88*	< 0.01*

Comparative analysis of variations in the experimental group (EGV) and variations in the control group (CGV) at the end of the 11th week study. To determine the variation within each of the groups was calculated the difference between the value of the variables obtained at the 11th week of the study and the value of the variables obtained at week zero, for every participant. The results were presented as mean ± standard deviation and 95% confidence interval (95%CI). MD refers to the mean of the differences. *Statistically significant results were marked with an asterisk and have been shown in boldface and italic

ISSN: 2523-3106